Matches in Nanopublications for { ?s ?p "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 16 of
16
with 100 items per page.
- NP242203.RAs9S-AiTyRHCBxGdaqPddo-QF0XdCr7qqI1w-cMJgvCY130_assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP242203.RAs9S-AiTyRHCBxGdaqPddo-QF0XdCr7qqI1w-cMJgvCY130_provenance.
- NP864182.RAq4_0ndFgY8Z_Tqiez4v8ApHAqxZWjmUsPDTUVeuOaSo130_assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864182.RAq4_0ndFgY8Z_Tqiez4v8ApHAqxZWjmUsPDTUVeuOaSo130_provenance.
- NP916853.RA2mEJWlEhIrptecj7rGnvHetN8x3v52XXZ0q-T2kTwjI130_assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916853.RA2mEJWlEhIrptecj7rGnvHetN8x3v52XXZ0q-T2kTwjI130_provenance.
- NP769603.RAxagAfDcxAmK48i-F1m4pZEw7jZeS9QbL2jG8M2S1Yps130_assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP769603.RAxagAfDcxAmK48i-F1m4pZEw7jZeS9QbL2jG8M2S1Yps130_provenance.
- NP759038.RAVdiDA5C2ENDNvgLaA_QGSLOwAG2_79-PiSTTEwbzGoM130_assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759038.RAVdiDA5C2ENDNvgLaA_QGSLOwAG2_79-PiSTTEwbzGoM130_provenance.
- NP949870.RARgZwc_7qo88wEZyceCwnP9kAtEoxWADBH3tVp_P-0-U130_assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949870.RARgZwc_7qo88wEZyceCwnP9kAtEoxWADBH3tVp_P-0-U130_provenance.
- assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP949856.RAvL7OwLXawoJ52Z7lIji3InMY3HnjvB4ZVn7AEzo5rzA130_assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949856.RAvL7OwLXawoJ52Z7lIji3InMY3HnjvB4ZVn7AEzo5rzA130_provenance.
- NP949861.RAij55JGuk4pUlxqSp81JcsW67wJySvO28Ek-pBVRkbGg130_assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949861.RAij55JGuk4pUlxqSp81JcsW67wJySvO28Ek-pBVRkbGg130_provenance.
- NP621739.RABUbksR5O7d3ErhhYCn0aPwopJOilRRA6wacUpX1P8yI130_assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621739.RABUbksR5O7d3ErhhYCn0aPwopJOilRRA6wacUpX1P8yI130_provenance.
- NP621742.RAAg09-41IW4dUfuLBA51MItHhSUAinwO0aAX5abWFMpA130_assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621742.RAAg09-41IW4dUfuLBA51MItHhSUAinwO0aAX5abWFMpA130_provenance.
- NP621737.RAkz0Mgo-IW0sekgN0XUBGa6Bi5rB0XWf9WzP6RYNOVNs130_assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621737.RAkz0Mgo-IW0sekgN0XUBGa6Bi5rB0XWf9WzP6RYNOVNs130_provenance.
- NP621740.RApQomAjonazyfYBNNe4H1PMROaNPaq_2v3wjGge2k300130_assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621740.RApQomAjonazyfYBNNe4H1PMROaNPaq_2v3wjGge2k300130_provenance.
- NP759306.RAwWTOasDHF1vpYRu7UyvbhLVI7zKRTiTtzciC1yY5aXU130_assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759306.RAwWTOasDHF1vpYRu7UyvbhLVI7zKRTiTtzciC1yY5aXU130_provenance.
- NP759894.RA4oJF7sUkMbmPSpxcm2V0Uika8Tt3K4HsUfkPTUXfMfU130_assertion description "[Our data indicate that ITIH5 is a candidate class II tumour suppressor gene and could be involved in tumour progression, invasion and metastasis, as its absence is associated with increased proliferation rates and a prognostic value indicating poor clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759894.RA4oJF7sUkMbmPSpxcm2V0Uika8Tt3K4HsUfkPTUXfMfU130_provenance.